Drug CategoryDrugIHD Dosing

Administration Timing Around HD Session

AntibioticsErythromycin250-500mg PO Q12HAdminister Anytime During HD

Molecular Weight    (Da)

Excreted Unchanged (%)Normal Half-Life (Hours)ESRD Half-Life (Hours)Plasma Protein Binding (%)Volume of Distribution (L/kg)Dialytic Plasma Clearance (ml/min)% Dialyzed
734151.45-660-950.6- (low flux)


  • Aronoff GR, Bennett WM, Berns JS, Brier ME, Kasbekar N, Mueller BA, et al. Drug Prescribing in Renal Failure. Philadelphia: American College of Physicians;2007.
  • DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL:
  • Iliopoulou A, Downey K, Chaput de Saintonge D, Turner P. Should erythromycin dose be altered in haemodialysis patients? European journal of clinical pharmacology 1982; 23(5), 435-40.
  • Kroboth P, McNeil M, Kreeger A, Dominguez J, Rault, R. Hearing loss and erythromycin pharmacokinetics in a patient receiving hemodialysis. Archives of internal medicine 1983; 143(6), 1263-5.
  • Mery J, Kanfer A. Hearing Loss and Erythromycin Pharmacokinetics in Patients Receiving Hemodialysis. Archives of internal medicine 1984; 144, 419-20.
  • Vaziri N, Cesario T, Valentic, J, Saiki J, Tilles J. Hemodialysis of Erythromycin. Drug Intelligence & Clinical Pharmacy 1980;4, 549-551.